Combination gene therapies targeting the biology of aging and age-related disease in companion animals and humans.
NASDAQ-listed clinical-stage biotech mining human aging data to discover metabolic and inflammatory-aging drugs.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →